191 related articles for article (PubMed ID: 24792094)
1. ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.
Koronyo-Hamaoui M; Shah K; Koronyo Y; Bernstein E; Giani JF; Janjulia T; Black KL; Shi PD; Gonzalez-Villalobos RA; Fuchs S; Shen XZ; Bernstein KE
Curr Hypertens Rep; 2014 Jul; 16(7):444. PubMed ID: 24792094
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.
Bernstein KE; Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Lopes DH; Shah KH; Bernstein EA; Fuchs DT; Yu JJ; Pham M; Black KL; Shen XZ; Fuchs S; Koronyo-Hamaoui M
J Clin Invest; 2014 Mar; 124(3):1000-12. PubMed ID: 24487585
[TBL] [Abstract][Full Text] [Related]
3. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
4. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
[TBL] [Abstract][Full Text] [Related]
5. Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging.
Le D; Brown L; Malik K; Murakami S
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947975
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme overexpression in myelocytes enhances the immune response.
Bernstein KE; Gonzalez-Villalobos RA; Giani JF; Shah K; Bernstein E; Janjulia T; Koronyo Y; Shi PD; Koronyo-Hamaoui M; Fuchs S; Shen XZ
Biol Chem; 2014 Oct; 395(10):1173-8. PubMed ID: 24633750
[TBL] [Abstract][Full Text] [Related]
7. The non-cardiovascular actions of ACE.
Cao D; Veiras L; Ahmed F; Shibata T; Bernstein EA; Okwan-Duodu D; Giani JF; Khan Z; Bernstein KE
Peptides; 2022 Jun; 152():170769. PubMed ID: 35182689
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?
Zou K; Michikawa M
Rev Neurosci; 2008; 19(4-5):203-12. PubMed ID: 19145983
[TBL] [Abstract][Full Text] [Related]
10. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.
de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
Curr Alzheimer Res; 2018 Feb; 15(4):386-398. PubMed ID: 29034839
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of myeloid angiotensin-converting enzyme (ACE) reduces atherosclerosis.
Okwan-Duodu D; Weiss D; Peng Z; Veiras LC; Cao DY; Saito S; Khan Z; Bernstein EA; Giani JF; Taylor WR; Bernstein KE
Biochem Biophys Res Commun; 2019 Dec; 520(3):573-579. PubMed ID: 31615657
[TBL] [Abstract][Full Text] [Related]
13. Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease.
Yamada K; Uchida S; Takahashi S; Takayama M; Nagata Y; Suzuki N; Shirakura S; Kanda T
Brain Res; 2010 Sep; 1352():176-86. PubMed ID: 20627092
[TBL] [Abstract][Full Text] [Related]
14. [Angiotensin converting enzyme and Alzheimer's disease].
Kugaevskaia EV
Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin converting enzyme serum activities: Relationship with Alzheimer's disease.
Zhuang S; Wang X; Wang HF; Li J; Wang HY; Zhang HZ; Xing CM
Brain Res; 2016 Nov; 1650():196-202. PubMed ID: 27608957
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ACE in Myeloid Cells Increases Immune Effectiveness and Leads to a New Way of Considering Inflammation in Acute and Chronic Diseases.
Veiras LC; Cao D; Saito S; Peng Z; Bernstein EA; Shen JZY; Koronyo-Hamaoui M; Okwan-Duodu D; Giani JF; Khan Z; Bernstein KE
Curr Hypertens Rep; 2020 Jan; 22(1):4. PubMed ID: 31916032
[TBL] [Abstract][Full Text] [Related]
17. ACE Phenotyping as a Guide Toward Personalized Therapy With ACE Inhibitors.
Danilov SM; Tovsky SI; Schwartz DE; Dull RO
J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):374-386. PubMed ID: 28587581
[TBL] [Abstract][Full Text] [Related]
18. The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer's-related disease and preserving cognition.
Danziger R; Fuchs DT; Koronyo Y; Rentsendorj A; Sheyn J; Hayden EY; Teplow DB; Black KL; Fuchs S; Bernstein KE; Koronyo-Hamaoui M
Front Physiol; 2023; 14():1179315. PubMed ID: 37427403
[TBL] [Abstract][Full Text] [Related]
19. Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease.
Hou DR; Wang Y; Zhou L; Chen K; Tian Y; Song Z; Bao J; Yang QD
Chin Med J (Engl); 2008 Nov; 121(22):2320-3. PubMed ID: 19080340
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme gene in Alzheimer's disease.
Yang YH; Liu CK
Tohoku J Exp Med; 2008 Aug; 215(4):295-8. PubMed ID: 18679002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
